OGA and Other metabolic disease: Furthermore, the OGT/OGA mRNA ratio was significantly higher in subcutaneous and visceral adipose tissue from patients with type 2 diabetes than in adipose tissue from non-diabetic patients, suggesting that elevated expression of OGT in adipose tissue may be a risk factor for obesity and metabolic diseases in humans [64].